| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. | Clin Cancer Res | 2009 | 1.20 |
| 2 | Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. | Int J Cancer | 2008 | 1.01 |
| 3 | Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase. | BMC Cancer | 2010 | 0.82 |
| 4 | VAV3 mediates resistance to breast cancer endocrine therapy. | Breast Cancer Res | 2014 | 0.78 |
| 5 | Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na. | Mol Cancer Ther | 2014 | 0.77 |